Iofina PLC Directorate Change (3041O)
04 November 2016 - 6:00PM
UK Regulatory
TIDMIOF
RNS Number : 3041O
Iofina PLC
04 November 2016
4 November 2016
Iofina Plc
("Iofina" or "the Company")
(LSE AIM: IOF)
PERMANENT APPOINTMENT OF CFO
Iofina, specialists in the exploration and production of iodine
and iodine specialty chemical derivatives, is pleased to announce
the appointment of Malcolm Lewin as Executive Director and Chief
Financial Officer ("CFO") to the Board with immediate effect.
Malcolm has served as the Company's interim CFO since February
2016, and that appointment has now been made permanent.
Malcolm is based out of the UK, and has over 30 years'
experience in finance and accounting at both public and private
companies. As well as being a partner in a chartered accountancy
firm for 11 years, he has acted as Finance Director or CFO for
various companies that are or have been listed on AIM, TSX-V and
NYSE-MKT global stock exchanges. Malcolm has an MA in Classics from
Oxford University and qualified as a chartered accountant with
Coopers & Lybrand.
Commenting on the news, President and CEO Dr. Tom Becker,
stated: "We are delighted to welcome Malcolm to the Board and
pleased that he has accepted a permanent role with us as CFO. We
have had the opportunity to get to know Malcolm over the period,
and are confident that he will continue to prove to be a
significant asset to the Company as it works towards the
opportunities that lie ahead. "
Additional information on Malcolm Lewin:
The following information is disclosed in accordance with
Schedule 2(g) of the AIM Rules for Companies.
Full name: Malcolm Thomas Lewin
Age: 65
Shares held: None
Directorships/partnerships held in the last five years:
Current Past
None None
There are no other matters which are required to be announced
for Malcolm Lewin pursuant to Schedule 2(g) of the AIM Rules for
Companies.
Enquiries:
Dr. Tom Becker, CEO & President
Iofina plc
Tel: +44 (0)20 3006 3135
Christopher Raggett/Giles Rolls/Joanna Scott
finnCap Ltd
Tel: +44 (0)20 7220 0500
Media Contact:
Dominic Barretto/Harriet Jackson
Yellow Jersey PR Limited
Tel: +44 (0)7544 275 882
About Iofina:
Iofina specialises in the exploration and production of iodine,
iodine specialty chemical derivatives and produced water. Iofina's
business strategy is to identify, develop, build, own and operate
iodine extraction plants currently focused in North America based
on Iofina's WET(R) IOsorb(R) technology. Iofina has operations in
the United States, specifically in Montana, Kentucky and Oklahoma.
It has complete vertical integration from the production of iodine
in the field to the manufacture of the chemical end-products
derived from iodine to the consumer and the recycling of iodine
using iodinated side-streams from waste chemical processes. Iofina
utilises its portfolio of patented and patent pending technology,
proprietary methods and trademarks throughout all business
lines.
www.iofina.com
This information is provided by RNS
The company news service from the London Stock Exchange
END
BOAUGGPWGUPQGMW
(END) Dow Jones Newswires
November 04, 2016 03:00 ET (07:00 GMT)